References
  1. Seaquist ER, Anderson J, Childs B, et al. hypoglycemia and diabetes: a report of a workgroup of the american diabetes association and the endocrine society. Diabetes Care. 2013;36:1384–1395.
  2. DeRosa MA & Cryer PE. Hypoglycemia and the sympathoadrenal system: neurogenic symptoms are largely the result of sympathetic neural, rather than adrenomedullary, activation. American journal of physiology. Endocrinology and metabolism 2004 287 E32-41
  3. Whipple AO. The surgical therapy of hyperinsulinismus. J Int Chir 1938 3 237-276.
  4. Whipple AO. Islet cell tumors of the pancreas. Canadian Medical Association journal 1952 66 334-342.
  5. Kittah N.E., Vella A. MANAGEMENT OF ENDOCRINE DISEASE: Pathogenesis and management of hypoglycemia Eur J Endocrinol 2017 Jul;177(1):R37-R47.
  6. Iqbal A, Heller S Managing hypoglycaemia Best Pract Res Clin Endocrinol Metab 2016 Jun;30(3):413-30.
  7. The Diabetes Control and Complications Trial Research Group. The effect of intensive insulin treatment of diabetes on the development and progression of long term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329:977–986.
  8. Cariou B, Fontaine P, Eschwege E. Frequency and predictors of confirmed hypoglycemia in type 1 and insulin-treated type 2 diabetes mellitus patients in a real-life setting: results from the DIALOG study. Diabetes Metabolism. 2015;41(2):116–125.
  9. Cryer PE. Preventing hypoglycaemia: what is the appropriate glucose alert value? Diabetologia 2009; 52(1): 35-7.
  10. Benson JW Jr, Johnson DG, Palmer JP. Glucagon and catecholamine secretion during hypoglycemia in normal and diabetic man. J Clin Endocrinol Metab. 1977 Mar;44(3):459–464.
  11. Cryer PE & Gerich JE. Glucose counterregulation, hypoglycemia, and intensive insulin therapy in diabetes mellitus. N Engl J Med 1985 313 232-241.
  12. Frier BM, Schernthaner G, Heller SR. Hypoglycemia and cardiovascular risks. Diabetes Care. 2011;34(suppl 2):S132–S137.
  13. Sanon V.P., Sanon S., Kanakia R. Et al. Hypoglycemia from a cardiologist’s perspective. Clin Cardiol. 2014 Aug;37(8):499-504. doi: 10.1002/clc.22288. Epub 2014 Jun 4.
  14. Wright RJ, Frier BM. Vascular disease and diabetes: is hypoglycaemia an aggravating factor? Diabetes Metab Res Rev. 2008;24:353-363.
  15. Singh P, Jain A, Kaur G. Impact of hypoglycemia and diabetes on CNS:correlation of mitochondrial oxidative stress with DNA damage. Mol Cell Biochem 2004;260:153–159
  16. Gogitidze Joy N, Hedrington MS, Briscoe VJ, Tate DB, Ertl AC, Davis SN. Effects of acute hypoglycemia on inflammatory and pro-atherothrombotic biomarkers in individuals with type 1 diabetes and healthy individuals. Diabetes Care 2010;33:1529–1535
  17. Wang J, Alexanian A, Ying R, et al. Acute exposure to low glucose rapidly induces endothelial dysfunction and mitochondrial oxidative stress: role for AMP kinase. Arterioscler Thromb Vasc Biol 2012;32:712–720
  18. Joy NG, Tate DB, Younk LM, Davis SN. Effects of acute and antecedent hypoglycemia on endothelial function and markers of atherothrombotic balance in healthy humans. Diabetes 2015;64:2571–2580
  19. Yasunari E., Mita T., Osonoi Y. Et al. Repetitive hypoglycemia increases circulating adrenaline level with resultant worsening of intimal thickening after vascular injury in male Goto-Kakizaki rat carotid artery 2014 Jun;155(6):2244-53.
  20. Al-Qaissi A, Papageorgiou M, Deshmukh H, et al. Effects of acute insulin-induced hypoglycaemia on endothelial microparticles in adults with and without type 2 diabetes. Diabetes Obes Metab. 2019 Mar;21(3):533-540.
  21. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985 Jul;28(7):412-9.
  22. Lang RM, Badano LP et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr (2015) 28(1):1–39.
  23. Shingu Y, Amorim P, Nguyen TD, et al. Myocardial performance (Tei) index is normal in diastolic and systolic heart failure induced by pressure overload in rats, Eur J Echocardiogr, Volume 11, Issue 10, December 2010, Pages 829–833.
  24. Stein JH, Korcarz CE, Hurst RT, et al. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine. American Society of Echocardiography Carotid Intima-Media Thickness Task Force. J Am Soc Echocardiogr. 2008 Feb; 21(2):93-111; quiz 189-90.
  25. Corretti MC, Anderson TJ, Benjamin EJ, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: A report of the International Brachial Artery Reactivity Task Force, J Am Coll Cardiol., Volume 39, Issue 2, 2002, Pages 257-265.
  26. Bots ML, Westerink J, Rabelink TJ, et al. Assessment of flow-mediated vasodilatation (FMD) of the brachial artery: effects of technical aspects of the FMD measurement on the FMD response, European Heart Journal, Volume 26, Issue 4, February 2005, Pages 363–368.
  27. Fisher BM, Gillen G, Dargie HJ, et al. The effects of insulin-induced hypoglycaemia on cardiovascular function in normal man: studies using radionuclide ventriculography. Diabetologia. 1987 Nov;30(11):841-5.
  28. Hsu PF, Sung SH, Cheng HM, et al. Association of clinical symptomatic hypoglycemia with cardiovascular events and total mortality in type 2 diabetes: a nationwide population-based study. Diabetes Care. 2013;36:894–900.
  29. The ADVANCE Collaborative Group (George Inst for International Health, Sydney, NSW, Australia; et al) Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes N Engl J Med 2008; 358:2560-2572
  30. The ORIGIN Trial Investigators. Basal insulin and cardiovascular and other outcomes in dysglycemia. N Engl J Med 2012;367:319-28.
  31. Finfer S, Heritier S; NICE Study Management Committee and SUGAR Study Executive Committee. The NICE-SUGAR (Normoglycaemia in Intensive Care Evaluation and Survival Using Glucose Algorithm Regulation) Study: statistical analysis plan. Crit Care Resusc. 2009 Mar;11(1):46-57.
  32. Heiskanen JS, Ruohonen S, Rovio SP, et al. Determinants of left ventricular diastolic function-The Cardiovascular Risk in Young Finns Study. Echocardiography. 2019 May;36(5):854-861.
  33. Novo G, Manno G, Russo R, et al. Impact of insulin resistance on cardiac and vascular function. Int J Cardiol. 2016 Oct 15;221:1095-9.
  34. Jelenik T, Flögel U, Álvarez-Hernández E, et al. Insulin Resistance and Vulnerability to Cardiac Ischemia. Diabetes. 2018 Dec;67(12):2695-2702.
  35. Askin L, Cetin M, Tasolar H, et al. Left ventricular myocardial performance index in prediabetic patients without coronary artery disease. Echocardiography. 2018 Apr;35(4):445-449.
  36. Sengul C, Cevik C, Ozveren O, et al. Echocardiographic epicardial fat thickness is associated with carotid intima-media thickness in patients with metabolic syndrome. Echocardiography. 2011 Sep;28(8):853-8.
  37. Sommerfield AJ, Wilkinson IB, Webb DJ, et al. Vessel Wall stiffness in type 1 diabetes and the central hemodynamic effects of acute hypoglycemia. Am J Physiol Endocrinol Metab. 2007;293:E1274–E1279.